Profiling Nonrecipients of Mass Drug Administration for Schistosomiasis and Hookworm Infections: A Comprehensive Analysis of Praziquantel and Albendazole Coverage in Community-Directed Treatment in Uganda | Zendy

Goylette F. Chami | Zendy; Andreas A. Kontoleon | Zendy; Erwin Bulte | Zendy; Alan Fenwick | Zendy; Narcis B. Kabatereine | Zendy; Edridah M. Tukahebwa | Zendy; David W. Dunne | Zendy

Open Access

Profiling Nonrecipients of Mass Drug Administration for Schistosomiasis and Hookworm Infections: A Comprehensive Analysis of Praziquantel and Albendazole Coverage in Community-Directed Treatment in Uganda

Author(s) -

Goylette F. Chami,

Andreas A. Kontoleon,

Erwin Bulte,

Alan Fenwick,

Narcis B. Kabatereine,

Edridah M. Tukahebwa,

David W. Dunne

Publication year - 2015

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/civ829

Subject(s) - albendazole , mass drug administration , medicine , praziquantel , socioeconomic status , environmental health , latrine , schistosomiasis , demography , immunology , helminths , sanitation , surgery , population , pathology , sociology

Repeated mass drug administration (MDA) with preventive chemotherapies is the mainstay of morbidity control for schistosomiasis and soil-transmitted helminths, yet the World Health Organization recently reported that less than one-third of individuals who required preventive chemotherapies received treatment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research